GS0051: pharmaceuticals for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genitourinary and central nervous system; pharmaceuticals for the treatment of cancer and pain; anti-infectives; bi-functional and multibinding compounds sold as a component of pharmaceutical preparations for the treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genitourinary and central nervous system and for the treatment of cancer and pain and for use as anti-infectives
Case File Event Statements
5/22/2015 - 9 years ago
17 - ABANDONMENT NOTICE MAILED - AFTER PUBLICATIONType:MAB5
5/22/2015 - 9 years ago
16 - ABANDONMENT - AFTER PUBLICATIONType:ABN5
5/21/2015 - 9 years ago
15 - TEAS EXPRESS ABANDONMENT RECEIVEDType:EXAR
12/10/2014 - 10 years ago
14 - NOTICE OF APPROVAL OF EXTENSION REQUEST MAILEDType:EXRA
12/8/2014 - 10 years ago
13 - EXTENSION 1 GRANTEDType:EX1G
12/8/2014 - 10 years ago
12 - EXTENSION 1 FILEDType:EXT1
12/8/2014 - 10 years ago
11 - TEAS EXTENSION RECEIVEDType:EEXT
6/25/2014 - 10 years ago
10 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN
6/10/2014 - 10 years ago
9 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM